Table 2 Characteristics of 4232 Nova Scotia seniors discharged from hospital with unstable angina or myocardial infarction
Characteristic | Statin Dispensed (n = 1629) | No Statin Dispensed (n = 2603) | p value |
|---|---|---|---|
Demographics | Â | Â | Â |
Age (years) (range) | 74.6 ± 5.7 (66-98 years) | 79.2 ± 7.1 (66-101 years) | < 0.0001 |
Gender (Males) | 49.8% | 47.1% | 0.085 |
Risk Factors/Comorbidities | Â | Â | Â |
Hypertension | 58.8% | 58.2% | 0.705 |
Smoking | Â | Â | < 0.0001 |
Never | 48.9% | 57.9% | Â |
Current | 18.00% | 13.5% | Â |
Past | 33.1% | 28.6% | Â |
Family history of CVD | 15.3% | 8.4% | < 0.0001 |
Diabetes | 26.2% | 29.0% | 0.047 |
History of CHF | 8.5% | 17.6% | < 0.0001 |
History of MI | 25.8% | 30.9% | 0.0004 |
History of Stroke | 6.4% | 11.5% | < 0.0001 |
History of TIA | 4.5% | 7.5% | < 0.0001 |
Number of distinct prescription medications in 6 months pre-hospitalization | 5.7 ± 4.2 | 6.6 ± 4.6 | < 0.0001 |
Area in Province Patient Resides | Â | Â | 0.035 |
North | 18.1% | 17.6% | Â |
Central | 35.1% | 32.5% | Â |
East | 21.7% | 20.8% | Â |
West | 25.0% | 29.0% | Â |
Factors During Index Hospitalization | |||
Discharge Diagnosis | Â | Â | Â |
Unstable Angina | 46.0% | 51.0% | 0.001 |
Myocardial Infarction | 54.0 % | 49.0% | Â |
In-hospital procedures | Â | Â | Â |
CABG | 6.0% | 3.7% | 0.0004 |
Cardiac catheterization | 27.1% | 15.6% | < 0.0001 |
PTCA | 10.8% | 5.7% | < 0.0001 |
EST | 48.8% | 25.1% | < 0.0001 |
Concomitant medications written at hospital discharge | Â | Â | Â |
ASA | 85.2% | 75.3% | < 0.0001 |
ACE inhibitor | 46.2% | 47.6% | 0.375 |
Beta-blocker | 83.1% | 75.9% | < 0.0001 |
Calcium channel blocker | 37.4% | 37.5% | 0.950 |
Fibrates | 6.1% | 4.9% | 0.0092 |
Cholesterol Levels measured in Hospital (Y/N) | Â | Â | Â |
Total cholesterol | 68.1% | 46.0% | < 0.0001 |
LDL cholesterol | 63.1% | 42.0% | < 0.0001 |
HDL cholesterol | 50.9% | 49.1% | < 0.0001 |
Triglycerides | 54.5% | 45.5% | < 0.0001 |
Factors Post-Index Hospitalization | |||
Follow-up (# years) | 2.7 ± 1.1 | 2.1 ± 1.2 | < 0.0001 |
Crude Mortality | 11.4% | 35.9% | < 0.0001 |